Causes of Upper Gastrointestinal Bleeding (UGIB)
Peptic ulcer disease is the leading cause of nonvariceal UGIB, accounting for 50-70% of cases, primarily driven by Helicobacter pylori infection and NSAID use. 1, 2, 3
Primary Etiologies of UGIB
Most Common Causes (Nonvariceal)
- Peptic ulcer disease represents the dominant etiology, with duodenal ulcers accounting for 28% and gastric ulcers for 32% of cases in large prospective series 4
- Gastric erosions and gastritis are particularly prevalent in critically ill patients and those with NSAID exposure 1, 2
- Esophagitis serves as an important cause of UGIB, often related to acid reflux or medication-induced injury 1, 3
- Mallory-Weiss tears occur from forceful vomiting and represent a common traumatic cause 1, 2
- Dieulafoy lesion accounts for 1-2% of acute bleeding cases, consisting of a tortuous submucosal artery that penetrates the gastric mucosa, typically on the posterior stomach wall 1, 2
Variceal Causes
- Esophageal varices represent 9% of UGIB cases and occur predominantly in patients with cirrhosis and portal hypertension, carrying high rebleeding risk and mortality 2, 4, 5
- Portal hypertensive gastropathy causes chronic bleeding in cirrhotic patients 5
Less Common but Important Causes
- Angiodysplasia and vascular malformations account for up to 80% of obscure bleeding cases and may require repeat endoscopy or advanced imaging for detection 2
- Upper GI malignancies including gastric cancer, esophageal cancer, and hepatocellular carcinoma eroding into the duodenum 1, 2
- Rare catastrophic causes include hemobilia (1 in 500 cases), hemosuccus pancreaticus, and aortoenteric fistula 1, 4
High-Risk Patient Populations and Medication-Related Bleeding
Anticoagulant and Antiplatelet Agents
- Warfarin combined with aspirin creates a 13-fold increased risk of UGIB compared to baseline, with bleeding occurring in 20% of patients receiving this combination therapy 6
- NSAIDs (ibuprofen, aspirin) cause serious GI bleeding in approximately 1% of patients treated for 3-6 months and 2-4% of patients treated for one year 7
- Aspirin at any dose increases UGIB risk at all levels of alcohol consumption, with regular use >325mg conferring a 7-fold increased risk among drinkers 8
Critical Risk Factors in Older Adults
- Coagulopathy increases absolute risk of stress-related UGIB by 4.8% 9, 10, 9
- Chronic liver disease increases absolute risk by 7.6%, the highest among identified risk factors 9, 10, 9
- Shock states increase absolute risk by 2.6% 9, 10, 9
- Prior history of peptic ulcer disease or GI bleeding confers a greater than 10-fold increased risk when combined with NSAID use 7
Compounding Risk Factors
- Smoking significantly increases rebleeding and mortality risk in UGIB patients 11
- Alcohol consumption independently increases UGIB risk, rising to 2.8-fold among those consuming ≥21 drinks/week, with highest incidence among heavy drinkers using aspirin or ibuprofen 8
- Advanced age represents an independent risk factor, with elderly patients at greatest risk for fatal GI events 7
- Concomitant corticosteroid use further elevates bleeding risk in NSAID users 7
Critical Clinical Context
- Spontaneous cessation occurs in 75-90% of cases, but mortality remains 2-14% despite this, emphasizing the need for risk stratification 2, 4
- Only one in five patients who develop serious upper GI adverse events on NSAID therapy experience warning symptoms beforehand 7
- Nasogastric aspirate may be negative in 3-16% of patients with confirmed UGIB, requiring early endoscopy for definitive diagnosis 1, 2